Henry Schein, Inc.

Health Care · Medical Specialities

Reference price$85.71As of Jul 28, 2026

Market capitalization$9.76B

52-week range$61.95–$89.34

S&P 500 portfolio weight0.01%

Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$64.00-25.3% vs. reference

Average$86.58+1.0% vs. reference

High$100.00+16.7% vs. reference

7 Buy5 Hold1 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 4, 2026Jun 2026

Consensus EPS$1.228 estimates

Expected range$1.17–$1.26Low to high EPS

Dec 2026$5.32Street EPS consensus

Dec 2027$5.82Street EPS consensus

Dec 2028$6.30Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 27, 2025.

MetricCurrentPrior

Revenue+4.0% YoY$13.18B$12.67B

Operating income$0.65B$0.62B

Net income$0.4B$0.39B

Operating cash flow$0.71B$0.85B

Capital expenditures($0.14B)($0.15B)

Current context

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.

Henry Schein, Inc.

Analyst targets

Current earnings expectations

Annual financial snapshot

Related news

Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?

Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders

DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion

Sources & method